Phase 2 Poor Graft Function Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Graft-Versus-Host DiseasePoor Graft FunctionLow Donor T-cell Chimerism

University of Liege100 enrolled12 locationsNCT00603330

Recruiting

Phase 2

REscuing bone marrow function in patients with aplaStic anaEmia and bone marrow faiLure post allogEneiC Transplantation (RESELECT) Phase I/II single arm with historical control study assessing the efficacy and safety of Atorvastatin and N-Acetyl Cysteine in the treatment of Poor Graft Function post allogeneic transplantation and relapsed/refractory aplastic anaemia

One of the health conditions being studied in this trial will be Poor Graft FunctionOne of the health conditions being studied in this trial will be Aplastic Anaemia

The Royal Melbourne Hospital20 enrolled1 locationACTRN12620001339943